The Italian government is seeking €1.2 billion in damages from Novartis and Roche for losses after allegations the two drugmakers colluded to direct patients with an eye disorder to a more expensive medicine. That resulted in damages to the Italian health system of €45 million in 2012, €540 million last ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.